Skip to main content

Cangrelor Dosage

Applies to the following strengths: 50 mg

Usual Adult Dose for Percutaneous Coronary Intervention

30 mcg/kg IV bolus prior to percutaneous coronary intervention (PCI) followed immediately by 4 mcg/kg/min IV infusion for at least 2 hours or for the duration of the PCI, whichever is longer

Use: Adjunct to PCI to reduce the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis in patients who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

No adjustment recommended

Dose Adjustments

Transitioning patients to oral P2Y12 therapy:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

Reconstitution/preparation techniques: Manufacturer product information should be consulted.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.